Protecting your equity, your rights, and your voice in Sino-foreign entities — from minority shareholder remedies to director liability, deadlock resolution, and corporate veil-piercing under China's evolving company law regime.
Corporate governance disputes in Sino-foreign entities are among the highest-stakes, most complex, and most emotionally charged matters we handle. When a joint venture breaks down, a minority shareholder is marginalized, or a director breaches fiduciary duties, the consequences extend far beyond litigation outcomes — they affect market access, brand reputation, and years of investment.
China's corporate legal framework has undergone transformative reform. The PRC Company Law was comprehensively revised with effect from July 1, 2024 — the most significant overhaul since the law's original enactment in 1993. The 2024 revision introduces strengthened minority shareholder protections, expanded grounds for derivative actions, refined director and officer duties, and enhanced mechanisms for resolving shareholder deadlock. For foreign investors in WFOEs, equity joint ventures, and cooperative joint ventures, these changes create both new opportunities and new compliance obligations.
At the same time, the Supreme People's Court has issued a series of judicial interpretations — notably SPC Judicial Interpretation IV on Company Law (公司法司法解释四, 2017) addressing shareholder rights, resolutions, and information rights, and Judicial Interpretation V (2019) on shareholder derivative actions and major asset sales, supplemented by the 2024 SPC Guiding Opinions on the implementation of the revised Company Law. Together, these instruments form a dense regulatory landscape that foreign investors must navigate with precision.
Majority shareholder withholds dividends despite sustained profitability; excludes minority director from board meetings; dilutes minority shareholding through related-party capital increases; diverts business opportunities to entities controlled by the majority shareholder — all while the minority shareholder's capital remains trapped.
Foreign shareholder requests access to the company's financial statements, articles of association, shareholder registers, and board resolutions — all of which are statutory inspection rights under the Company Law — and the Chinese management or majority shareholder refuses or provides only incomplete, unaudited records.
Chinese partner transfers equity to a third party without offering the foreign shareholder a right of first refusal, forges signatures on transfer documents, or transfers at an undervalued price — often to a related party — in violation of statutory pre-emption rights and transfer restrictions.
Director or senior officer — often the Chinese partner's nominee — engages in self-dealing, misappropriates company funds, competes with the company, usurps corporate opportunities, or fails to exercise the diligence expected of a reasonable director, causing significant corporate loss.
Joint venture board is evenly split and cannot approve budgets, appoint officers, or declare dividends. No tie-breaking mechanism exists. The company is paralyzed — unable to operate effectively but also unable to dissolve without the parties' agreement or a court order.
Foreign shareholder seeks to exit through capital reduction but the Chinese partner blocks the procedure, disputes the valuation, or refuses to cooperate with the statutory creditor-notification and registration-formality requirements, effectively trapping the foreign party's investment.
The 2024 Company Law (2023修订, effective July 1, 2024) is the primary statute governing corporate governance in China. Key changes relevant to foreign investors include:
The Supreme People's Court has issued critical judicial interpretations that fill gaps and provide practical guidance:
The 2024 Company Law represents a clear legislative trend toward stronger minority shareholder protection — a shift that benefits foreign investors who often hold minority positions in Sino-foreign JVs. However, statutory rights are only as effective as the enforcement strategy behind them. Procedural compliance — including the pre-suit demand requirements for derivative actions — must be meticulously observed.
The 2024 Company Law and SPC Judicial Interpretation IV together provide a toolbox of remedies for minority shareholders — but each remedy has specific procedural prerequisites, evidentiary burdens, and strategic implications.
Under Article 188 of the 2024 Company Law, any shareholder (regardless of ownership percentage in a limited liability company; 1%+ continuous 180-day holding in a joint stock company) may bring a derivative action on behalf of the company against directors, supervisors, senior management, or third parties who have caused harm to the company. Pre-suit demand on the board of supervisors (or board of directors, in certain cases) is mandatory, and failure to comply with the demand procedure is a common basis for dismissal. The 2024 revision introduced a "double derivative action" mechanism allowing parent-company shareholders to bring derivative claims on behalf of wholly-owned subsidiaries — particularly relevant for foreign investors holding through intermediate structures.
Article 57 of the 2024 Company Law grants shareholders the right to inspect and copy the company's articles of association, shareholder register, minutes of shareholder meetings, board resolutions, supervisor resolutions, and financial reports. Shareholders may also request inspection of accounting books and supporting vouchers (会计账簿、会计凭证), though this right is subject to a written request stating a proper purpose. The SPC Judicial Interpretation IV (2017) strengthens these rights by: (a) deeming "improper purpose" defenses narrowly; (b) allowing shareholders to engage accountants, lawyers, and other professionals to assist in the inspection; and (c) creating a statutory cause of action where inspection is wrongfully denied. If the company refuses, the shareholder may file suit within 15 days of the refusal.
Article 89 of the 2024 Company Law provides that shareholders who vote against certain fundamental corporate actions — including significant asset sales, mergers, and (under specified conditions) continuous non-distribution of profits — may demand that the company purchase their shares at a "fair price." If the company and shareholder cannot agree on price within 60 days, the shareholder may file suit within 30 days thereafter. This remedy is particularly relevant where the majority shareholder is using profit retention and non-distribution as a tool of oppression.
A significant innovation of the 2024 Company Law (Article 89, paragraph 3): where a controlling shareholder abuses their position to seriously damage the interests of the company or other shareholders, the other shareholders have the right to demand that the controlling shareholder purchase their equity at a fair price. This effectively creates a statutory exit right for minority shareholders facing oppression, without needing to prove grounds for judicial dissolution. The provision is new and its scope will be defined through early case law, but it represents a potentially powerful remedy for foreign minority investors in JVs.
The doctrine of "piercing the corporate veil" (揭开公司面纱 / 公司人格否认) is codified in Article 23 of the 2024 Company Law — making China one of the relatively few civil law jurisdictions with an express statutory basis for disregarding corporate personality.
Article 23 provides that where a shareholder abuses the company's independent legal personality and limited liability to evade debts and seriously damage the interests of creditors, the shareholder shall bear joint and several liability for the company's debts. Chinese courts have identified the following indicia:
The 2024 revision of Article 23 introduces horizontal veil-piercing: where a shareholder controls two or more companies and abuses that control to commingle assets, evade debts, or cause loss to creditors, the controlled companies may be held jointly liable for each other's debts. This fills a critical gap in the pre-2024 law, which only permitted vertical piercing (shareholder liable for subsidiary's debts).
For foreign creditors dealing with Chinese corporate groups where assets have been moved among related entities to evade enforcement, the 2024 horizontal piercing provision is potentially game-changing. However, the evidentiary burden is substantial — Chinese courts require clear and convincing evidence of abuse, and veil-piercing remains an exceptional remedy, not a routine one. We work with forensic accountants to build the evidentiary foundation for veil-piercing claims from the earliest stages of a dispute.
Directors, supervisors, and senior management personnel of Chinese companies owe two core duties under Article 180 of the 2024 Company Law: the duty of loyalty (忠实义务) — the obligation to avoid conflicts of interest and not to use one's position for personal gain — and the duty of diligence (勤勉义务) — the obligation to exercise the care, skill, and diligence that a reasonable person would exercise in managing their own affairs. These duties, while broadly similar in concept to common-law fiduciary duties, have distinct contours under Chinese law.
Serious breaches of fiduciary duty may also attract criminal liability under the PRC Criminal Law, including: duty encroachment (职务侵占罪, Article 271) for misappropriation of company property; misappropriation of funds (挪用资金罪, Article 272); and bribery of non-state functionaries (对非国家工作人员行贿罪, Article 164). The 2024 Criminal Law Amendment (XII) expanded the scope of criminal liability for private-sector corruption, bringing it closer in severity to public-sector anti-corruption standards. Foreign-invested enterprises should be aware that internal investigations into director misconduct may uncover facts triggering mandatory reporting obligations or criminal exposure for both the individual and the company.
We begin with a comprehensive forensic review: corporate registration records, articles of association, shareholders' agreements, board and shareholder meeting minutes, financial statements (audited and management accounts), related-party transaction registers, and bank records. Where necessary, we engage forensic accountants to trace asset flows and identify indicia of commingling, diversion, or self-dealing. This investigative phase often uncovers leverage points that shape the entire dispute strategy.
We systematically enforce statutory shareholder rights as both a remedy in themselves and a means of building the evidentiary record: formal inspection demands under Article 57; petitions to convene extraordinary shareholder meetings; challenges to the validity of board and shareholder resolutions under Judicial Interpretation IV; and applications for court-supervised access to accounting records. The exercise of these rights often prompts settlement discussions by demonstrating that the foreign shareholder is serious and sophisticated.
Where the company's interests have been harmed by directors, officers, or controlling shareholders who are unwilling to cause the company to sue, we bring shareholder derivative actions under Article 188 (and the double-derivative mechanism, where applicable). We handle the entire procedural sequence — pre-suit demand, court filing, evidence submission, and trial — with experience in the nuances that distinguish Chinese derivative actions from their Delaware or English counterparts.
Litigation is not always the optimal outcome. Where the commercial objective is a clean exit at a fair price, we negotiate buyouts — leveraging appraisal rights, judicial dissolution petitions as negotiation anchors, and the new abusive-shareholder buyout remedy under Article 89(3) — to extract the best available terms. We coordinate valuation work, tax structuring, and the regulatory formalities of equity transfer registration with AIC to ensure a clean, enforceable exit.
Represented a European manufacturing company holding 40% of a Sino-foreign JV in Jiangsu Province. The Chinese majority shareholder systematically excluded the European director from board meetings, withheld financial information for 3+ years, diverted JV business to a related company, and refused to declare dividends despite accumulated profits of RMB 180 million. We deployed a multi-pronged strategy: formal information-rights enforcement under Article 57, a petition for judicial dissolution as negotiation leverage, parallel derivative claims against the Chinese director for breach of fiduciary duty, and structured buyout negotiations. Achieved a negotiated buyout at 1.3x the independent valuation — approximately RMB 94 million — with full payment within 90 days.
Represented a US technology company's WFOE in claims against its former General Manager, who — during his employment and for 18 months thereafter — diverted supplier relationships to a competing company he secretly established in his spouse's name, misappropriated RMB 14 million in company funds, and caused the loss of a key customer contract. Coordinated a parallel civil derivative action (breach of fiduciary duty) and criminal complaint (duty encroachment under Criminal Law Article 271). The former GM was convicted and sentenced to 5 years' imprisonment; the WFOE recovered RMB 11.2 million through criminal restitution and civil enforcement.
Whether you are structuring a new Sino-foreign entity, facing a governance deadlock, or need to enforce your shareholder rights against an obstructive partner, we are ready to help. Contact us for a confidential, no-obligation discussion.
Contact Danny Luo